AptaBio Therapeutics Inc. (293780.KQ)
KRW 6500.0
(-3.56%)
KRW 6500.0
(-3.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 323.86 Million | 48.35 Million | 223.67 Million | 341.04 Million | 1.01 Billion | 1.45 Billion |
| Cost of Revenue | 245.36 Million | 11.14 Million | 4.32 Million | 4.07 Million | 4.11 Million | - |
| Gross Profit | 78.49 Million | 37.2 Million | 219.35 Million | 336.96 Million | 1.01 Billion | 1.45 Billion |
| Operating Expenses | 16.45 Billion | 9.07 Billion | 11.24 Billion | 6.13 Billion | 8.07 Billion | 4.8 Billion |
| Selling, General and Administrative Expenses | 3.93 Billion | 2.79 Billion | 2.1 Billion | 2.25 Billion | 2.58 Billion | 1.32 Billion |
| Research and Development Expenses | 12.38 Billion | 6.19 Billion | 9.07 Billion | 3.82 Billion | 5.45 Billion | 3.45 Billion |
| Other Expenses | - | -74.48 Million | -64.29 Million | -55.3 Million | -33.59 Million | -19.43 Million |
| Cost and Expenses | 16.69 Billion | 9.53 Billion | 11.56 Billion | 6.38 Billion | 8.16 Billion | 4.81 Billion |
| Operating Income | -16.37 Billion | -9.48 Billion | -11.34 Billion | -6.04 Billion | -7.15 Billion | -3.36 Billion |
| Interest Expense | 1.18 Billion | 4.49 Million | 1.83 Million | 2.29 Million | 2.03 Million | 647.93 Million |
| Income Tax Expense | -2.63 Billion | 460.16 Million | 319.83 Million | 249.8 Million | 95.33 Million | - |
| Earnings before Tax | -14.68 Billion | -10.56 Billion | -10.68 Billion | -3.91 Billion | -6.29 Billion | -4.06 Billion |
| Net Income | -12.06 Billion | -10.56 Billion | -10.68 Billion | -3.91 Billion | -6.29 Billion | -4.06 Billion |
| Earnings Per Share Basic | -540.91 | -473.98 | -711.76 | -177.89 | -289.38 | -186.45 |
| Earnings Per Share Diluted | -540.91 | -473.98 | -711.76 | -177.89 | -289.38 | -186.45 |
| Weighted Average Shares Outstanding | 22.29 Million | 22.28 Million | 15.01 Million | 22.02 Million | 21.76 Million | 21.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.29 Million | 22.28 Million | 15.01 Million | 22.02 Million | 21.76 Million | 21.79 Million |
| Gross Margin | 0.24 | 0.77 | 0.98 | 0.99 | 1.00 | 1.00 |
| EBIT Margin | -40.15 | -186.59 | -49.28 | -17.00 | -6.93 | -2.31 |
| Profit Margin | -37.24 | -218.49 | -47.79 | -11.49 | -6.18 | -2.79 |
| EBITDA | -13 Billion | -10.09 Billion | -10.36 Billion | -3.66 Billion | -6.2 Billion | -3.4 Billion |
| Earnings Before Tax Margin | -50.56 | -196.11 | -50.71 | -17.73 | -7.02 | -2.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.12 Billion | 637.23 Million | 323.86 Million | 289.2 Million | 8.38 Million | 6.78 Million |
| Cost of Revenue | 1.19 Billion | 682.59 Million | 745.47 Million | 1.04 Billion | - | - |
| Gross Profit | -74.86 Million | -45.36 Million | -421.6 Million | -759.47 Million | 8.38 Million | 6.78 Million |
| Operating Expenses | 4.15 Billion | 3.05 Billion | 16.44 Billion | 5.31 Billion | 4.09 Billion | 2.87 Billion |
| Selling, General and Administrative Expenses | 1.8 Billion | 1.15 Billion | - | 494.6 Million | 795.72 Million | 1.05 Billion |
| Research and Development Expenses | 2.32 Billion | 1.87 Billion | - | 4.78 Billion | 3.26 Billion | 1.76 Billion |
| Other Expenses | -22.5 Million | -21.53 Million | -130.02 Million | -31.32 Million | -32.1 Million | -51.1 Million |
| Cost and Expenses | 5.35 Billion | 3.73 Billion | 17.18 Billion | 6.36 Billion | 4.21 Billion | 3 Billion |
| Operating Income | -4.23 Billion | -3.09 Billion | -16.86 Billion | -6.07 Billion | -4.2 Billion | -2.99 Billion |
| Interest Expense | 966.9 Million | 906.55 Million | 1.18 Billion | 834.94 Million | 342.2 Million | 2.83 Million |
| Income Tax Expense | 240.96 Million | 55.62 Million | 4.4 Billion | 4.4 Billion | -1.00 | 124.36 Million |
| Earnings before Tax | -6.79 Billion | -3.91 Billion | -14.68 Billion | -3.89 Billion | -4.16 Billion | -2.15 Billion |
| Net Income | -7.03 Billion | -3.96 Billion | -19.09 Billion | -8.3 Billion | -4.16 Billion | -2.15 Billion |
| Earnings Per Share Basic | -301.35 | -177.89 | - | -372.57 | -186.98 | -96.51 |
| Earnings Per Share Diluted | -301.35 | -177.89 | - | -372.57 | -186.98 | -96.51 |
| Weighted Average Shares Outstanding | 23.33 Million | 22.29 Million | 22.29 Million | 22.29 Million | 22.29 Million | 22.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.33 Million | 22.29 Million | 22.29 Million | 22.29 Million | 22.29 Million | 22.29 Million |
| Gross Margin | -0.07 | -0.07 | -1.30 | -2.63 | 1.00 | 1.00 |
| EBIT Margin | -3.67 | -4.67 | - | -20.57 | -487.05 | -422.87 |
| Profit Margin | -6.28 | -6.22 | -58.97 | -28.73 | -497.16 | -317.23 |
| EBITDA | -4.11 Billion | -2.97 Billion | - | -5.94 Billion | -4.08 Billion | -2.86 Billion |
| Earnings Before Tax Margin | -3.78 | -4.86 | -52.07 | -21.00 | -501.71 | -441.22 |
950160
129260
JELLF
CPA
RSE
CANSF